Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 14, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 5
- 0 vs. Q2 2022
- Portfolio value
- $142.7M
- +$37.7M (+35.9%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| DICEDICE Therapeutics, Inc. | COM | 3,292,871 | $66.8M | 46.8% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 4,214,498 | $38.4M | 26.9% | 00.0% | Unchanged | History |
| TBIOTelesis Bio Inc. | COM | 9,844,130 | $16.3M | 11.5% | 00.0% | Unchanged | History |
| ISOIsoPlexis Corp | COM | 8,808,531 | $15.2M | 10.6% | 00.0% | Unchanged | History |
| CADLCandel Therapeutics, Inc. | COM | 1,935,215 | $6.08M | 4.3% | 00.0% | Unchanged | History |